Emcure Pharma IPO Date, Price, GMP, Review, Details

Emcure Pharmaceuticals Limited IPO

The Emcure Pharma has begun on 03-July-2024. It will close on 05-July-2024. The Total IPO Size is 1,952.03 Crore. The company set its IPO price is 960-1008 Rs Per Share.

There are three basic categories in Emcure Pharma IPO Subscription 1) Qualified Institutional Buyers 2) Non-Institutional Investors 3) Qualified Institutional Buyers.

Emcure Pharma was incorporated in 1981.

Emcure Pharma is a leading Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products.

They were ranked as (i) the 13th largest pharmaceutical company in India in terms of Domestic Sales for MAT September 2023, (ii) the 4th largest pharmaceutical company by market share, and the largest pharmaceutical company in the gynecology and human immunodeficiency virus (“HIV”) antivirals therapeutic areas in India.

They also sell differentiated products internationally in over 70 countries, with a strong presence in India, Europe, and Canada.

They have 13 manufacturing facilities across India.

Emcure Pharma Promoters

Satish Mehta and Sunil Mehta are Promotors of the company.

Emcure Pharma IPO Date, Details & Price Band

The Emcure Pharma IPO Price Band, IPO Dates, Market lot, and other details are mentioned in the below table.

IPO Opening Dates 03-July-2024
IPO Closing Dates 05-July-2024
Price Band 960-1008 Rs
Fresh Issue 1,152.03 Crore
Offer for sale size 1,152.03 Crore
Total IPO size 1,952.03 Crore
Minimum bid (lot size) 14 Shares
Face Value 10 INR Per Share
Issue Type Book Built Issue IPO
QIB Allocation 50%
HNI Allocation 15%
Retail Allocation 35%
Listing On NSE, BSE

Emcure Pharma IPO Market Lot

The Emcure Pharma IPO minimum market lot is 14 shares With 14,112 ₹ Amount per application.

Lot No of Shares Amount
Retail Minimum 1 14 14,112 ₹
Retail Maximum 13 196 197,568 ₹

Restated Financial Record of the three years (Amt. in Crore)

Total Assets Total Revenue Profit After Tax
31-Mar-24 7,806.16 6,715.24 527.58
31-Mar-23 6,672.53 6,031.72 561.85
31-Mar-22 6,063.47 5,918.86 702.56

Emcure Pharma IPO GMP & Grey Market Premium

Emcure Pharma IPO GMP Grey market premium has been started today. Check the Latest Emcure Pharma IPO GMP, Kostak Rates, and Subject to Sauda Price here.

Emcure Pharma IPO Prospectus

Emcure Pharma IPO Prospectus Available on BSE and Sebi Website as well as on our Portal. Please click here to Download the Emcure Pharma IPO Prospectus.

Emcure Pharma IPO Prospectus Download
DRHP Download
RHP Download
Anchor List Download

Emcure Pharma IPO Form Download

Emcure Pharma IPO form is Available on NSE, BSE Website as well as on our Portal. Please click here to Download Emcure Pharma IPO forms.

Emcure Pharma IPO Allotment Date & Details

Allotment Date 08-July-2024
Initiation of refunds 09-July-2024
Transfer of shares to Demat accounts 09-July-2024
Listing Date 10-July-2024
Check Allotment Status Click here

Registrar of Emcure Pharma

Link Intime India Private Limited
C-101, 1st Floor, 247 Park
Lal Bahadur Shastri Marg, Vikhroli (West)
Mumbai 400 083
Maharashtra, India
Tel: + 91 810 811 4949
E-mail: [email protected]
Website: www.linkintime.co.in
Investor grievance e-mail:
[email protected]
Contact Person: Shanti Gopalkrishnan
SEBI Registration No.: INR000004058

Emcure Pharma Contact Details

Emcure Pharmaceuticals Limited
Plot No. P-1 and P-2,
IT-BT Park, Phase II, M.I.D.C.,
Hinjawadi, Pune -411 057
Phone: +91 20 3507 0033
Email: [email protected]
Website: https://www.emcure.com/

Emcure Pharma IPO Lead Managers

Kotak Mahindra Capital Company Limited
1st Floor, C-27 BKC
Plot No. 27, ‘G’ Block, Bandra Kurla
Complex, Bandra (East)
Mumbai 400 051
Maharashtra, India
Tel: + 91 22 4336 0000
E-mail: [email protected]
Investor grievance e-mail:
[email protected]
Contact Person: Ganesh Rane
SEBI Registration No.: INM000008704

Axis Capital Limited
1st Floor, Axis House
C-2 Wadia International Centre
Pandurang Budhkar Marg, Worli
Mumbai 400 025
Maharashtra, India
Tel: +91 22 4325 2183
E-mail: [email protected]
Website: www.axiscapital.co.in
Investor grievance e-mail:
[email protected]
Contact Person: Sagar Jatakiya
SEBI Registration No.: INM000012029

Jefferies India Private Limited
16th Floor, Express Towers,
Nariman Point
Mumbai 400 021
Maharashtra, India
Tel: +91 22 4356 6000
E-mail: [email protected]
Website: www.jefferies.com
Investor grievance e-mail:
[email protected]
Contact Person: Suhani Bhareja
SEBI Registration No.: INM000011443

J.P. Morgan India Private Limited
J.P. Morgan Tower, Off CST Road,
Santacruz East
Mumbai 400 098
Maharashtra, India
Tel: + 91 22 6157 3000
E-mail: [email protected]
Website: www.jpmipl.com
Investor grievance e-mail:
[email protected]
Contact Person: Aanchal Mittal/
Saarthak Soni
SEBI Registration No.: INM000002970